Manufacturers: Help us map vaccine and mAb manufacturing in Europe to strengthen pandemic preparedness

The European Vaccines Hub (EVH), mandated by HERA, is inviting manufacturers - CMOs, CDMOs, biopharma companies - to share information on GMP vaccine and monoclonal antibody manufacturing capabilities in Europe.

This EU wide mapping initiative will support future pandemic preparedness and emergency response collaborations.

We’re looking for insight on:

• GMP compliant facilities in Europe specializing in vaccines and mAbs
• Scale up & scale out manufacturing capacity
• Regulatory and quality experitise
• Experience in technology transfer and public health collaboration


• Take the survey by downloading the PDF and return to production@zepai.de
  Deadline: February 1st 2026
  
  Your contribution supports Europe’s strategic readiness and future preparedness efforts.
  
  The survey is coordinated by the Center for Pandemic Vaccines and Therapeutics (ZEPAI) at the Paul-Ehrlich-Institut (Germany) as part of the EVH project, supported by NIPH (Norway), LUMC (Netherlands) and FBS (Italy).